Cormorant Asset Management, LP

Position in ERAS — Erasca, Inc.

CIK 1583977 BOSTON, MA

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$93,844,000

+$72,541,906 QoQ

Shares Held

5,800,000

-46.4% QoQ

Ownership

1.87%

of shares outstanding

% of Portfolio

4.73%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. ERAS ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	885,500	$285,299,245
2	BBOT	BridgeBio Oncology Therapeutics, Inc.	17,878,594	$160,013,416
3	EYPT	EyePoint, Inc.	8,265,000	$106,535,850
4	EWTX	Edgewise Therapeutics, Inc.	3,260,000	$102,690,000
5	ERAS	Erasca, Inc. This page	5,800,000	$93,844,000
6	RAPP	Rapport Therapeutics, Inc.	2,957,521	$92,540,832
7	ALMS	Alumis Inc.	3,949,241	$87,001,779
8	ABVX	Abivax S.A.	760,000	$84,626,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$93,844,000	5,800,000	-46.4%	Shares	Defined	2026-05-15
2023-09-30	$21,302,094	10,813,246	0.0%	Shares	Defined	2023-11-14
2023-06-30	$29,844,558	10,813,246	0.0%	Shares	Defined	2023-08-14
2023-03-31	$32,547,870	10,813,246	0.0%	Shares	Defined	2023-05-15
2022-12-31	$46,605,090	10,813,246	+2.9%	Shares	Defined	2023-02-14
2022-09-30	$81,943,321	10,505,554	0.0%	Shares	Defined	2022-11-14
2022-06-30	$58,515,935	10,505,554	0.0%	Shares	Defined	2022-08-15
2022-03-31	$90,347,764	10,505,554	+0.0%	Shares	Defined	2022-05-16
2021-12-31	$163,676,469	10,505,550	0.0%	Shares	Defined	2022-02-14
2021-09-30	$222,927,771	10,505,550	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.